Pharmacological blockade of these nutrient transporters might offer a novel strategy in cancer therapy: “starve the tumor cells to death” [46], so a small-molecule inhibitor with minimal toxicity targeting SLC6A14 is worth seeking. Here, SLC6A14 is linked to cancer.